Baxter International Inc BAX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$42.23M (5 inflow days, 15 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 48.8% of shares outstanding.
Largest holders
By investor type
Reported short interest has held roughly steady near 4.58% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| Citadel Advisors LLC | Hedge Fund | 2026/Q4 | +4,758,748 | 1.0% |
| AQR Capital Management | Hedge Fund | 2026/Q4 | +4,575,540 | 1.3% |
| Freestone Grove Partners LP | Hedge Fund | 2026/Q4 | +2,110,084 | 0.5% |
| Morgan Stanley | Public Company | 2026/Q4 | +1,243,621 | 0.8% |
| Columbia Management Investment Advisers, LLC | Mutual Fund | 2026/Q4 | +1,144,436 | 0.3% |
| Nomura Holdings, Inc. | Public Company | 2026/Q4 | +1,066,596 | 0.2% |
| WEDGE Capital Management LLP | Mutual Fund | 2026/Q4 | +1,065,501 | 0.2% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q4 | +813,504 | 1.1% |
| Citigroup Inc. | Public Company | 2026/Q4 | +595,821 | 0.2% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q4 | +545,166 | 0.1% |
| Aegon Asset Management UK Plc | Mutual Fund | 2026/Q4 | +537,953 | 0.1% |
| Trexquant Investment LP | Hedge Fund | 2026/Q4 | +419,388 | 0.1% |
| Mariner, LLC | Mutual Fund | 2026/Q4 | +368,806 | 0.1% |
| Strategic Advisers LLC | Mutual Fund | 2026/Q4 | +351,921 | 3.7% |
| Millennium Management LLC | Hedge Fund | 2026/Q4 | +348,108 | 0.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 30 Sep 2026 | John Rogers | Chief Financial Officer | Initial Statement of Beneficial | +0 | – | – |
| 14 Sep 2026 | Bernie Heine | Interim Chief Accounting Officer & Controller | Initial Statement of Beneficial | +0 | – | 32,840 |
| 1 Sep 2026 | Andrew Hider | CEO, Pres., Interim Group Pres. of Medical Products & Therapies and Director | Sale to Issuer | -54,276 | $25.70 | 71,276 |
| 1 Sep 2026 | Julie Foster | President of Front Line Care | Sale to Issuer | -2,098 | $25.70 | 29,164 |
| 31 Aug 2026 | James Teaff | President of Care & Connectivity Solutions | Sale to Issuer | -750 | $25.48 | 30,370 |
| 1 Jun 2026 | Steven Wallace | President of Advanced Surgery & Commercial Excellence | Sale to Issuer | -153 | $18.68 | 70,128 |
| 1 Jun 2026 | James Teaff | President of Care & Connectivity Solutions | Sale to Issuer | -321 | $18.68 | 31,063 |
| 31 May 2026 | Anita Zielinski | Former Interim CFO, Senior VP, Chief Accounting Officer & Controller | Other Acquisition | +13,426 | – | 55,705 |
| 4 May 2026 | Michael McDonnell | Independent Director | Other Acquisition | +12,836 | – | 14,647 |
| 4 May 2026 | Amy McBride-Wendell | Independent Director | Other Acquisition | +12,836 | – | 44,235 |
| 4 May 2026 | Patricia Morrison | Independent Director | Other Acquisition | +12,836 | – | 42,386 |
| 4 May 2026 | Nancy Schlichting | Independent Director | Other Acquisition | +12,836 | – | 34,994 |
| 4 May 2026 | David Shafer | Independent Chairperson | Other Acquisition | +12,836 | – | 72,804 |
| 4 May 2026 | Jeffrey Craig | Independent Director | Other Acquisition | +12,836 | – | 23,662 |
| 4 May 2026 | David Wilkes | Independent Director | Other Acquisition | +12,836 | – | 37,076 |
| 4 May 2026 | William Ampofo | Independent Director | Other Acquisition | +12,836 | – | 30,375 |
| 31 Mar 2026 | Steven Wallace | President of Advanced Surgery & Commercial Excellence | Initial Statement of Beneficial | +0 | – | 67,972 |
| 31 Mar 2026 | Julie Foster | President of Front Line Care | Initial Statement of Beneficial | +0 | – | 25,862 |
| 31 Mar 2026 | James Teaff | President of Care & Connectivity Solutions | Initial Statement of Beneficial | +0 | – | 55,119 |
| 5 Mar 2026 | Joel Grade | Former Chief Financial Officer | Sale to Issuer | -8,153 | $17.69 | 74,520 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 23,674,982 | 4.6% | 3.0 |
| 15 Oct 2026 | 23,765,665 | 4.6% | 4.2 |
| 30 Sep 2026 | 24,366,869 | 4.7% | 3.0 |
| 15 Sep 2026 | 23,227,313 | 4.5% | 4.5 |
| 31 Aug 2026 | 23,293,667 | 4.5% | 5.0 |
| 14 Aug 2026 | 23,914,369 | 4.6% | 3.0 |
No comments yet — be the first to weigh in on BAX.
Sign in to join the discussion.